Option chain shows key data for Rapid Micro Biosystems's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Rapid Micro Biosystems.

Rapid Micro Biosystems (NASDAQ:RPID) Stock, Option Chain

Rapid Micro Biosystems

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Apple Store Fifth Avenue

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AAPL

AMGN

ARDX

AXTI

BBAI

EXPE

FTNT

JAGX

LLAP

LOCO

MRIN

NAOV

OSPN

RPID

STEM

TRUP

VAXX

Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Long Ideas

Penny Stocks

CORT

Kintara Therapeutics, Inc. - Common Stock

KTRA

MIST

MOTS

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Top 5 Health Care Stocks That Could Lead To Your Biggest Gains in January

Insider Trades

ASPS

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

The Dow Jones closed higher by around 75 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Cardio Diagnostics And 2 Other Penny Stocks Insiders Are Buying

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems Inc

Rapid Micro Biosystems reports mixed Q2 results; reaffirms FY24 outlook

Rapid Micro Biosystems, Inc. (RPID) Q2 2024 Earnings Call Transcript

Rapid Micro Biosystems (RPID) has received a new Buy rating, initiated by TD Cowen analyst, Steven Mah. Steven Mah has given his Buy rating due to ...

Buy Rating Affirmed for Rapid Micro Biosystems Amid Strong Revenue Growth and Strategic Cost-Saving Initiatives

Morgan Stanley analyst Tejas Savant maintained a Hold rating on Rapid Micro Biosystems (RPID – Research Report) today and set a price target of $1....

Morgan Stanley Remains a Hold on Rapid Micro Biosystems (RPID)

Rapid Micro Biosystems GAAP EPS of -$0.26 in-line, revenue of $7.6M beats by $1.05M

Reports Q3 revenue $7.6M vs. $6.1M last year. "We are pleased to report record quarterly revenue, accelerating system placements and a positive inf...

Rapid Micro Biosystems reports Q3 EPS (26c) vs. (31c) last year

The Company is reaffirming its full year 2024 total revenue guidance of at least $27.0 million, representing growth of at least 20% compared to ful...

Rapid Micro Biosystems reaffirms FY24 revenue view of at least $27M

TD Cowen analyst Brendan Smith maintained a Buy rating on Rapid Micro Biosystems (RPID – Research Report) today. The company's shares opened today ...

TD Cowen Reaffirms Their Buy Rating on Rapid Micro Biosystems (RPID)

Rapid Micro Biosystems, Inc. (RPID) Q3 2024 Earnings Call Transcript

Rapid Micro Biosystems, Inc. Class A ( ($RPID) ) has released its Q3 earnings. Here is a breakdown of the information Rapid Micro Biosystems, Inc. ...

Rapid Micro Biosystems Reports Strong Q3 2024 Growth

Press Releases

Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum

Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024

Biotech

General

Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024

Earnings

Rapid Micro Biosystems Reports First Quarter 2024 Financial Results

Rapid Micro Biosystems to Announce Second Quarter 2024 Financial Results on August 2, 2024

Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results

Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Rapid Micro Biosystems to Announce Third Quarter 2024 Financial Results on November 1, 2024

Comments

Rapid Micro Biosystems

Rapid Micro Biosystems (RPID) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga